Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 579.00
Bid: 570.00
Ask: 588.00
Change: -3.00 (-0.52%)
Spread: 18.00 (3.158%)
Open: 580.00
High: 582.00
Low: 575.00
Prev. Close: 582.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Day and Trading Update

17 Feb 2021 07:00

RNS Number : 3112P
Marlowe PLC
17 February 2021
 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

17 February 2021

 

 

Marlowe plc

 

Capital Markets Day and Trading Update

 

Marlowe plc ("Marlowe" or the "Group"), the UK leader in business-critical services and software which assure safety and regulatory compliance, will be hosting a virtual Capital Markets Day at 10:00 a.m. today for institutional and retail investors and sell-side analysts.

 

At the event, senior executives and operational management will provide greater insight into the Group's businesses and operating model and set out a new divisional reporting structure that reflects the current scope of the Group. In addition, management will set out the Group's medium-term growth strategy including new financial targets.

 

- Three-Year Growth Target: The Group will set out its strategy for both organic and acquisition-led growth with the target of achieving revenue of c.£500 million and adjusted EBITDA of c.£100 million over the next three years. Run-rate revenue is currently £245 million and run rate adjusted EBITDA is currently £37 million.

 

- Updated Adjusted EBITDA Margin Target: The Group will be setting a new medium-term adjusted divisional EBITDA margin target of 20% (updated from previous 15% target) which it aims to achieve in the next three years. Run rate adjusted divisional EBITDA margin is currently c.16%.

 

- New Divisional Structure: Reflecting the transformation in scope, scale and quality of earnings of the Group, Marlowe will now report as the following two divisions:

 

o Governance, Risk and Compliance ('GRC') - providing Health & Safety, Employment Law/HR & Occupational Health assurance services and EHS, Compliance & eLearning software solutions.

 

o Testing, Inspection and Certification ('TIC') - providing recurring testing and inspection regimes across Fire Safety & Security, Water Treatment & Air Hygiene and Contractor Compliance.

 

The Group has continued to demonstrate its resilience in spite of the ongoing COVID-19 related lockdown restrictions. Trading in the second half remains strong and results* for the year ending 31 March 2021 are expected to be at the top end of current market expectations.

 

Participants can register for the live webcast using the following link:

 

https://www.investis-live.com/marloweplc/60080f942fb49a0a00420899/hwrt

 

A video replay of the event will be made available through the Marlowe website at www.marloweplc.com.

 

 

* Current analyst forecasts for FY21 adjusted EBITDA range from £23.6 million to £26.3 million (source: Reuters, 16 February 2021).

 

 

For further information:

 

Marlowe plc

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

 

Berenberg (Joint Broker)

Tel: +44 (0)20 3207 7800

Mark Whitmore

Ben Wright

Yudith Karunaratna

 

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

 

About Marlowe plc

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 15% of Britain's commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

Forward Looking Statements

This Announcement contains certain forward-looking statements with respect to certain of the Group's current expectations and projections about future events and the Company's future financial condition and performance. These statements, which sometimes use words such as "aim", "anticipate", "believe", "may", "will", "should", "intend", "plan", "assume", "estimate", "expect", "target", "anticipate", "could", "predict", "continue", "positioned", "risk" (or the negative thereof) and words of similar meaning, reflect the Directors' current beliefs, expectations and/or aspirations and involve known and unknown risks, uncertainties and assumptions, many of which are outside the Group's control and difficult to predict, that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. Any forward-looking statements made in this Announcement by or on behalf of the Company speak only as of the date they are made. These forward-looking statements reflect the Company's judgment at the date of this Announcement and are not intended to give any assurance as to future results and cautions that its actual results of operations and financial condition may differ materially from those made in or suggested by the forward-looking statements contained in this Announcement and/or information incorporated by reference into this Announcement. Except as required by the FCA, the London Stock Exchange, the AIM Rules or applicable law, the Company expressly disclaims any obligation or undertaking to release publicly any updates, supplements or revisions to any forward-looking statements contained in this Announcement to reflect any changes in the Company's expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based, except where required to do so under applicable law. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANAKFADFEFA
Date   Source Headline
2nd Mar 20217:00 amRNSAcquisitions
26th Feb 20217:00 amRNSAppointment of Chief Financial Officer
22nd Feb 20215:20 pmRNSDirector/PDMR Shareholding
17th Feb 20213:30 pmRNSCapital Markets Day Replay
17th Feb 20217:00 amRNSCapital Markets Day and Trading Update
10th Feb 20217:00 amRNSNotice of Capital Markets Day
5th Feb 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
4th Feb 20217:00 amRNSAcquisition Hadrian Technology Limited
28th Jan 20212:45 pmRNSHolding(s) in Company
7th Jan 20217:00 amRNSAcquisition of WPL Limited
29th Dec 20204:40 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSAcquisition of DeltaNet International Limited
11th Dec 20206:07 pmRNSHolding(s) in Company
11th Dec 202011:25 amRNSResult of General Meeting
7th Dec 20207:00 amRNSAcquisition of Network of Staff Supporters Limited
3rd Dec 20207:00 amRNSHalf Year Results
1st Dec 20204:10 pmRNSCompletion of Acquisition
30th Nov 20207:00 amRNSAcquisition of Wrightway Health Limited
26th Nov 20203:30 pmRNSNotice of General Meeting
20th Nov 20207:00 amRNSCompletion of Refinancing
17th Nov 202011:59 amRNSHolding(s) in Company
3rd Nov 202010:58 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSAcquisition of Black & Banton
30th Oct 202011:55 amRNSHolding(s) in Company
29th Oct 20206:08 pmRNSHolding(s) in Company
29th Oct 20207:00 amRNSResults of the Placing
28th Oct 20205:08 pmRNSAcquisition of Ellis Whittam and Proposed Placing
30th Sep 202012:06 pmRNSResult of AGM
25th Sep 20207:00 amRNSAcquisition of Morgan Fire Protection Limited
9th Sep 20207:00 amRNSFurther re Acquisition of William Martin
2nd Sep 20207:00 amRNS2020 SAYE Scheme & Director/PDMR Shareholdings
31st Jul 20202:46 pmRNSIssue of Equity and Director/PDMR Shareholding
31st Jul 20207:00 amRNSAcquisitions
17th Jul 202012:20 pmRNSHolding(s) in Company
15th Jul 202011:20 amRNSResult of General Meeting
8th Jul 20204:03 pmRNSGrant of Share Options
8th Jul 20207:00 amRNSFinal Results
30th Jun 202011:57 amRNSHolding(s) in Company
26th Jun 20202:39 pmRNSResults of the Placing
26th Jun 20207:00 amRNSAcquisition of Elogbooks and Proposed Placing
29th May 20207:00 amRNSAcquisition of Deminos Consulting Limited
12th May 20207:00 amRNSYear End Trading Statement and COVID-19 Update
7th Apr 202012:40 pmRNSIssue of Equity
7th Apr 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDisposal of non-core activities
31st Mar 20207:00 amRNSUpdate on COVID-19
24th Mar 202011:31 amRNSIssue of Equity
11th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSAcquisition of Solve HR Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.